Amgen, Inc.

( )
AMGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. 0.03%705.602.6%$682.64m
AMGNAmgen, Inc. -0.51%229.801.4%$637.83m
MRNAModerna, Inc. -0.45%121.600.0%$630.90m
GILDGilead Sciences, Inc. 0.00%63.931.0%$522.23m
BIIBBiogen, Inc. -2.01%271.051.8%$454.14m
VRTXVertex Pharmaceuticals, Inc. -0.17%291.911.9%$390.67m
ILMNIllumina, Inc. -1.93%197.403.2%$317.46m
SNSSSunesis Pharmaceuticals, Inc. 0.00%4.370.7%$305.48m
SAVACassava Sciences, Inc. 0.96%44.260.0%$196.86m
BNTXBioNTech SE -1.11%132.300.0%$108.50m
NVAXNovavax, Inc. -0.92%19.4375.6%$89.24m
BMRNBioMarin Pharmaceutical, Inc. 0.00%85.844.2%$84.06m
NRBONeuroBo Pharmaceuticals, Inc. 0.08%13.350.0%$76.94m
TECHBio-Techne Corp. 0.00%289.654.5%$75.91m
EXASEXACT Sciences Corp. 0.00%34.4417.6%$74.81m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.